CATALENT, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-12-18: Reporting owner McErlane David; Form 4; Security Option to purchase Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-12-18: Reporting owner Maselli Alessandro; Form 4; Security Options to purchase Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-12-18: Reporting owner Maselli Alessandro; Form 4; Security Options to purchase Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-12-18: Reporting owner Maselli Alessandro; Form 4; Security Options to purchase Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | McErlane David Officer (Group President, Biologics) | 4 | Option to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,740 0 owned after | $45.79 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,093 0 owned after | $23.89 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,375 0 owned after | $36.02 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,523 0 owned after | $43.88 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,735 0 owned after | $54.94 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,395 0 owned after | $88.10 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,568 0 owned after | $113.00 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,427 0 owned after | $107.63 exercise price | 2024-12-18 | |
| 2024-12-18 | Maselli Alessandro Director, Officer (President & CEO) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,360 0 owned after | $48.90 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,550 0 owned after | $36.02 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,622 0 owned after | $43.88 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,650 0 owned after | $54.94 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,055 0 owned after | $88.10 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,565 0 owned after | $113.00 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,828 0 owned after | $107.63 exercise price | 2024-12-18 | |
| 2024-12-18 | Hopson Ricky Officer (Pres. BioProduct Delivery, CoS) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,669 0 owned after | $46.51 exercise price | 2024-12-18 | |
| 2024-12-18 | Masanovich Matti Officer (SVP, Chief Financial Officer) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −81,082 0 owned after | $44.76 exercise price | 2024-12-18 | |
| 2024-12-18 | GREISCH JOHN J Director, Officer (Executive Chair) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −127,096 0 owned after | $48.98 exercise price | 2024-12-18 | |
| 2024-12-18 | Evoli Lisa Officer (SVP, Chief HR Officer) | 4 | Options to purchase Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,225 0 owned after | $46.51 exercise price | 2024-12-18 | |
| 2024-01-16 | Hatzfeld Michael Officer (Chief Accounting Officer) | 4 | Options to purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,981 3,981 owned after | $49.42 exercise price | 2024-01-18 |